Cytokinetics Analyst Ratings
Cytokinetics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $90 Price Target
Cytokinetics Analyst Ratings
Cytokinetics Analyst Ratings
Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and Canopy Growth (CGC)
Truist Financial Sticks to Its Buy Rating for Cytokinetics (CYTK)
Cytokinetics Analyst Ratings
Buy Rating Justified for Cytokinetics Amid Strong Capital Position and Promising Drug Pipeline
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Medtronic (MDT) and Cytokinetics (CYTK)
Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating
Cytokinetics: Strong Buy Rating Backed by Significant Financial Support and Promising Pipeline
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Soleno Therapeutics (SLNO)
Cytokinetics Analyst Ratings
Cytokinetics (CYTK) Receives a Buy From Barclays
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Hims & Hers Health (HIMS) and Cytokinetics (CYTK)
Buy Rating Justified by Cytokinetics' Aficamten Favorable Trial Data and Safety Profile
Cytokinetics Analyst Ratings
Cytokinetics (CYTK) Gets a Hold From Bank of America Securities
Jefferies Keeps Their Buy Rating on Cytokinetics (CYTK)